Condition: Diabetic Neuropathy, Painful · Sponsor: Rigshospitalet, Denmark
The goal of this clinical trial is to test perineural injections (injections around a nerve) of incobotulinumtoxin-A in participants with diabetic nerve pain of the feet and lower legs. The main questions it aims to answer are: * Is the treatment safe and effective? * Does the treatment affect participants quality of life, depression, physical activity, daily life, and sensation? Participants will be treated every 12 weeks, for a total of 24 weeks, with either incobotulinumtoxin-A or a placebo.
This description comes directly from the study's public registry record.
Marc Klee Olsen, MD · +4538633030 · marc.klee.olsen@regionh.dk
Trine Thomsen, MsC · +4538632712 · trine.hoermann.thomsen@regionh.dk
Always discuss trial participation with your own doctor first.
| Rigshospitalet Glostrup | Glostrup Municipality, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05623111